Stem cell derived basal forebrain cholinergic neurons from Alzheimer’s disease patients are more susceptible to cell death
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
An early substantial loss of basal forebrain cholinergic neurons (BFCNs) is a constant feature of Alzheimer's disease (AD) and is associated with deficits in spatial learning and memory. Induced pluripotent stem cells (iPSCs) derived from patients with AD as well as from normal controls could be efficiently differentiated into neurons with characteristics of BFCNs. We used BFCNs derived from iPSCs to model sporadic AD with a focus on patients with ApoE3/E4 genotypes (AD-E3/E4). BFCNs derived from AD-E3/E4 patients showed typical AD biochemical features evidenced by increased Aβ42/Aβ40 ratios. AD-E3/E4 neurons also exhibited altered responses to treatment with γ-secretase inhibitors compared to control BFCNs or neurons derived from patients with familial AD. BFCNs from patients with AD-E3/E4 also exhibited increased vulnerability to glutamate-mediated cell death which correlated with increased intracellular free calcium upon glutamate exposure. The ability to generate BFCNs with an AD phenotype is a significant step both for understanding disease mechanisms and for facilitating screening for agents that promote synaptic integrity and neuronal survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“or other easily accessible tissues and can then be differentiated into neurons [12,13].”
BackgroundCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“As a major risk factor in sporadic AD, the ApoE4 allele is associated with earlier onset and increased amyloid plaques in AD [37-39].”
BackgroundAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · cited 1×
“The etiology of AD is poorly understood, but there are consistent pathologic features of diseased brains including senile plaques composed of β-amyloid [3,4], and neurofibrillary tangles formed by hyperphosphorylated tau [5].”
BackgroundAlzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 1×
“The progressive cognitive decline of AD is a consequence of loss of synapses and eventually neurons in basal forebrain, cortex and hippocampus [8,9].”
BackgroundExcitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658 · cited 1×
“Human ApoE4 carriers have poorer recovery after head trauma or stroke [52,53] with severe neurodegeneration [54].”
BackgroundObservations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 1×
“The etiology of AD is poorly understood, but there are consistent pathologic features of diseased brains including senile plaques composed of β-amyloid [3,4], and neurofibrillary tangles formed by hyperphosphorylated tau [5].”
BackgroundIwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731 · cited 1×
“Aβ40 is normally the major form of secreted Aβ peptide recovered from cerebrospinal fluid, while Aβ42 represents less than 10% [6].”
BackgroundThe role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 1×
“It is well recognized that the ApoE4 allele accelerates the onset of AD [35], and the late onset for AG05810 suggests less of an effect of the ApoE4 allele.”
BackgroundSchmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 1×
“The progressive cognitive decline of AD is a consequence of loss of synapses and eventually neurons in basal forebrain, cortex and hippocampus [8,9].”
BackgroundProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · cited 3×
“Mixed neuronal cultures derived in such a way from AD patients displayed some biochemical features of the disease including increased Aβ42/40 ratios, elevated levels of Aβ42 or Aβ40, and increased phosphorylation of tau [14-16].”
BackgroundResultChin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.06.008 · Cited by 1,035 · cited 1×
“Although iPSCs are similar to hESCs, they are not identical and can have differences such as differential promoter methylation states and gene expression patterns [18].”
BackgroundShi, Y., Kirwan, P., & Livesey, F. J. (2012) · Nature Protocols · doi:10.1038/nprot.2012.116 · Cited by 972 · cited 1×
“Although retinoic acid (RA) may have some caudalizing effects, its use for generating forebrain precursors is well established [32,33].”
BackgroundHoltzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 1×
“Animal studies demonstrated an isoform-dependent (ApoE4 >ApoE3 >ApoE2) effect on Aβ deposition [40,41].”
BackgroundAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · cited 1×
“Compared to individuals with an ApoE3/E3 genotype, the presence of one copy of the E4 allele increases AD risk by 2 to 3 fold, and two copies of E4 increases risk up to 12 fold [1,2].”
BackgroundHuman ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage
Elkabetz, Y., Panagiotakos, G., Al Shamy, G., Socci, N. D., Tabar, V., & Studer, L. (2008) · Genes & Development · doi:10.1101/gad.1616208 · Cited by 677 · cited 4×
“1 and forebrain specific marker Forse1 [34], confirming the presence of a ventral forebrain progenitor population.”
BackgroundInfluentialModeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599 · cited 3×
“Mixed neuronal cultures derived in such a way from AD patients displayed some biochemical features of the disease including increased Aβ42/40 ratios, elevated levels of Aβ42 or Aβ40, and increased phosphorylation of tau [14-16].”
BackgroundResultApolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · cited 1×
“Since astrocytes are the primary sources of secreted ApoE in mice, and have been shown to bind and degrade amyloid deposits [43,44], the above effects are thought to be primarily mediated by astroctyes.”
BackgroundSource specificity of early calcium neurotoxicity in cultured embryonic spinal neurons
Tymianski, M., Charlton, M., Carlen, P., & Tator, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02085.1993 · Cited by 567 · cited 1×
“We found calcium influx through VSCCs did not differ significantly between one control and ApoE3/E4 line, consistent with previous findings of a lack of contribution by VSCCs to calcium mediated excitotoxicity [66,67].”
ResultMolecular Mechanisms of Glutamate Receptor-Mediated Excitotoxic Neuronal Cell Death
Sattler, R., & Tymianski, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:107 · Cited by 537
Molecular mechanisms of calcium-dependent excitotoxicity
Sattler, R., & Tymianski, M. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000077 · Cited by 477 · cited 1×
“Neuronal excitotoxicity is thought to be mediated by calcium dependent processes [30].”
BackgroundThe Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam, M. (2004) · Learning & Memory · doi:10.1101/lm.69204 · Cited by 467 · cited 1×
“AD-related tauopathies arise earliest in cholinergic neurons of the basal forebrain and loss of these neurons parallels cognitive decline [10,11].”
BackgroundNeuronal and glial calcium signaling in Alzheimer’s disease
Mattson, M. P., & Chan, S. L. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00128-3 · Cited by 457 · cited 1×
“The precise mechanisms of neuronal death in AD are still unclear, but multiple proposed mechanisms ultimately converge on disrupted calcium signaling [28].”
BackgroundDifferentiation of mouse embryonic stem cells into a defined neuronal lineage
Bibel, M., Richter, J., Schrenk, K., Tucker, K. L., Staiger, V., Korte, M., Goetz, M., & Barde, Y.-A. (2004) · Nature Neuroscience · doi:10.1038/nn1301 · Cited by 450 · cited 1×
“Although retinoic acid (RA) may have some caudalizing effects, its use for generating forebrain precursors is well established [32,33].”
BackgroundButtini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. E., Wyss-Coray, T., Mucke, L., & Mahley, R. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04867.1999 · Cited by 360 · cited 1×
“showed that neuron-specific expression of ApoE4 promotes excitotoxic cortical neuron death, whereas ApoE4 expressed by astrocytes was as neuroprotective as ApoE3 [59,60].”
BackgroundHuman cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295 · cited 1×
“To further confirm the phenotype of these cells, we examined expression of two markers characteristic of BFCNs, the low affinity neurotrophin receptor p75 shown be to expressed by over 95% of BFCNs [26] and Nkx2.”
BackgroundWolfe, M. S., Xia, W., Moore, C. L., Leatherwood, D. D., Ostaszewski, B., Rahmati, T., Donkor, I. O., & Selkoe, D. J. (1999) · Biochemistry · doi:10.1021/bi982562p · Cited by 289 · cited 1×
“Such an Aβ rise at sub-threshold concentrations of γ-secretase inhibitors has been described in cell culture [47,48] and in vivo in human [49].”
BackgroundApolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation
Slooter, A. J. C. (1997) · JAMA · doi:10.1001/jama.277.10.818 · Cited by 286 · cited 1×
“Human ApoE4 carriers have poorer recovery after head trauma or stroke [52,53] with severe neurodegeneration [54].”
BackgroundLiu, Y., Weick, J. P., Liu, H., Krencik, R., Zhang, X., Ma, L., Zhou, G.-M., Ayala, M., & Zhang, S.-C. (2013) · Nature Biotechnology · doi:10.1038/nbt.2565 · Cited by 276 · cited 1×
“Some approaches for the differentiation of hESCs and iPSCs are inefficient for generating BFCNs [31], and we used an approach that included retinoic acid followed by specific factors to induce a forebrain phenotype (SHH and FGF8) and nuclefection with two transcription factors (Lhx8 and Gbx1) that specify the BFCNs ph…”
MethodHuman APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., & Paul, S. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0887-09.2009 · Cited by 274 · cited 1×
“Animal studies demonstrated an isoform-dependent (ApoE4 >ApoE3 >ApoE2) effect on Aβ deposition [40,41].”
BackgroundSattler, R., Charlton, M. P., Hafner, M., & Tymianski, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062349.x · Cited by 273 · cited 1×
“We found calcium influx through VSCCs did not differ significantly between one control and ApoE3/E4 line, consistent with previous findings of a lack of contribution by VSCCs to calcium mediated excitotoxicity [66,67].”
ResultGenome-wide association studies in Alzheimer’s disease
Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257
Zhao, Y., Marín, O., Hermesz, E., Powell, A., Flames, N., Palkovits, M., Rubenstein, J. L. R., & Westphal, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537759100 · Cited by 227 · cited 1×
“Two transcription factors, Lhx8 and Gbx1, are crucial for BFCNs specification from committed progenitors in mice [24,25], and we have previously demonstrated that Lhx8 and Gbx1 are both necessary and sufficient for BFCNs induction from hESC-derived neurospheres [17].”
BackgroundImpact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease
Tiraboschi, P., Hansen, L. A., Masliah, E., Alford, M., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000128091.92139.0f · Cited by 226 · cited 1×
“As a major risk factor in sporadic AD, the ApoE4 allele is associated with earlier onset and increased amyloid plaques in AD [37-39].”
BackgroundSiemers, E., Skinner, M., Dean, R. A., Gonzales, C., Satterwhite, J., Farlow, M., Ness, D., & May, P. C. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000167360.27670.29 · Cited by 216 · cited 1×
“Such an Aβ rise at sub-threshold concentrations of γ-secretase inhibitors has been described in cell culture [47,48] and in vivo in human [49].”
BackgroundMufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Specific Regional Transcription of Apolipoprotein E in Human Brain Neurons
Xu, P.-T., Gilbert, J. R., Qiu, H.-L., Ervin, J., Rothrock-Christian, T. R., Hulette, C., & Schmechel, D. E. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65305-9 · Cited by 176 · cited 1×
“Neurons also express ApoE [45,46], and our data suggest that neuronal ApoE4 increases secretion of Aβ42, the more fibrillar form that is more likely to aggregate and act as the core for amyloid plaques.”
BackgroundBissonnette, C. J., Lyass, L., Bhattacharyya, B. J., Belmadani, A., Miller, R. J., & Kessler, J. A. (2011) · Stem Cells · doi:10.1002/stem.626 · Cited by 175
Self-citationFaedo, A., Borello, U., & Rubenstein, J. L. R. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0307-10.2010 · Cited by 169 · cited 3×
“Quantitative PCR demonstrated up-regulation of levels of the SHH downstream molecules Ptch1 and Shh [21] and the FGF8 downstream molecules Etv5 and Spry2 [22,23] (Figure 1A).”
BackgroundInfluentialHedgehog signaling pathway and gastrointestinal stem cell signaling network (Review)
Katoh, Y., & Katoh, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.6.1019 · Cited by 168 · cited 4×
“Quantitative PCR demonstrated up-regulation of levels of the SHH downstream molecules Ptch1 and Shh [21] and the FGF8 downstream molecules Etv5 and Spry2 [22,23] (Figure 1A).”
BackgroundInfluentialTolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148 · cited 1×
“Recombinant truncated or full-length ApoE protein elicited rapid elevation of intracellular calcium and induced rodent cortical or hippocampal neuron death [61,62].”
BackgroundFGF-Regulated Etv Genes Are Essential for Repressing Shh Expression in Mouse Limb Buds
Zhang, Z., Verheyden, J. M., Hassell, J. A., & Sun, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.008 · Cited by 146 · cited 3×
“Quantitative PCR demonstrated up-regulation of levels of the SHH downstream molecules Ptch1 and Shh [21] and the FGF8 downstream molecules Etv5 and Spry2 [22,23] (Figure 1A).”
BackgroundInfluentialApolipoprotein E Isoform-Specific Differences in Outcome from Focal Ischemia in Transgenic Mice
Sheng, H., Laskowitz, D. T., Bennett, E., Schmechel, D. E., Bart, R. D., Saunders, A. M., Pearlstein, R. D., Roses, A. D., & Warner, D. S. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199804000-00003 · Cited by 142 · cited 15×
“It is well recognized that the ApoE4 allele accelerates the onset of AD [35], and the late onset for AG05810 suggests less of an effect of the ApoE4 allele.”
ResultInfluentialJordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 139
Self-citationLiraz, O., Boehm-Cagan, A., & Michaelson, D. M. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-16 · Cited by 118
Fragkouli, A., Hearn, C., Errington, M., Cooke, S., Grigoriou, M., Bliss, T., Stylianopoulou, F., & Pachnis, V. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04141.x · Cited by 103 · cited 1×
“Two transcription factors, Lhx8 and Gbx1, are crucial for BFCNs specification from committed progenitors in mice [24,25], and we have previously demonstrated that Lhx8 and Gbx1 are both necessary and sufficient for BFCNs induction from hESC-derived neurospheres [17].”
BackgroundOntogeny of cholinergic neurons in the mouse forebrain
Schambra, U. B., Sulik, K. K., Petrusz, P., & Lauder, J. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902880109 · Cited by 102 · cited 1×
“Sonic hedgehog (SHH) and FGF8 signaling are involved in patterning BFCNs precursors in the medial ganglion eminence (MGE) during the development of ventral forebrain [19,20] and are required for BFCNs generation from hESCs [17].”
BackgroundAmyloid β‐Protein, APOE Genotype and Head Injury
NICOLL, J. A. R., ROBERTS, G. W., & GRAHAM, D. I. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34431.x · Cited by 96 · cited 1×
“Human ApoE4 carriers have poorer recovery after head trauma or stroke [52,53] with severe neurodegeneration [54].”
BackgroundMetzger, R. E., LaDu, M. J., Pan, J. B., Getz, G. S., Frail, D. E., & Falduto, M. T. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00013 · Cited by 94
Biochemical Characterization of the γ-Secretase Activity That Produces β-Amyloid Peptides
Zhang, L., Song, L., Terracina, G., Liu, Y., Pramanik, B., & Parker, E. M. (2001) · Biochemistry · doi:10.1021/bi0028800 · Cited by 93
Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis
Veinbergs, I., Everson, A., Sagara, Y., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10138 · Cited by 90 · cited 1×
“effect of ApoE4 in transgenic mice [64].”
The Relationship between Amyloid and Tau
Hardy, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:203 · Cited by 80 · cited 1×
“The etiology of AD is poorly understood, but there are consistent pathologic features of diseased brains including senile plaques composed of β-amyloid [3,4], and neurofibrillary tangles formed by hyperphosphorylated tau [5].”
BackgroundButtini, M., Masliah, E., Yu, G.-Q., Palop, J. J., Chang, S., Bernardo, A., Lin, C., Wyss-Coray, T., Huang, Y., & Mucke, L. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090973 · Cited by 80 · cited 1×
“showed that neuron-specific expression of ApoE4 promotes excitotoxic cortical neuron death, whereas ApoE4 expressed by astrocytes was as neuroprotective as ApoE3 [59,60].”
BackgroundNew therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
Corona, C., Pensalfini, A., Frazzini, V, & Sensi, S. L. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.57 · Cited by 80 · cited 1×
“AD mutations have been reported to deregulate calcium signaling and sensitize neurons to apoptosis [29].”
BackgroundMüller, W., Meske, V., Berlin, K., Scharnagl, H., März, W., & Ohm, T. G. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00190.x · Cited by 67
Tucker, E. S., Segall, S. K., Gopalakrishna, D., Wu, Y., Vernon, M., Polleux, F., & LaMantia, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2341-08.2008 · Cited by 65 · cited 1×
“Sonic hedgehog (SHH) and FGF8 signaling are involved in patterning BFCNs precursors in the medial ganglion eminence (MGE) during the development of ventral forebrain [19,20] and are required for BFCNs generation from hESCs [17].”
BackgroundThe Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression
Burton, C. R., Meredith, J. E., Barten, D. M., Goldstein, M. E., Krause, C., Kieras, C. J., Sisk, L. M., Iben, L. G., Polson, C. T., Thompson, M. W., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804175200 · Cited by 63 · cited 1×
“The underlying biochemical mechanism is not fully understood, but it is thought to be a direct γ-secretase effect [50,51].”
BackgroundRapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide
Wang, X.-S., & Gruenstein, E. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199710)173:1<73::aid-jcp9>3.0.co;2-g · Cited by 53 · cited 1×
“Recombinant truncated or full-length ApoE protein elicited rapid elevation of intracellular calcium and induced rodent cortical or hippocampal neuron death [61,62].”
BackgroundOoi, L., Sidhu, K., Poljak, A., Sutherland, G., O’Connor, M. D., Sachdev, P., & Münch, G. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-012-0839-2 · Cited by 48 · cited 1×
“Inter-line variance could also account for some of the differences since we used retrovirus to generate our iPSCs, and genome integration could lead to clonal heterogeneity and potential functional diversity [36].”
MethodMagno, L., Catanzariti, V., Nitsch, R., Krude, H., & Naumann, T. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.050 · Cited by 31 · cited 1×
“1 reported to persist in postmitotic BFCNs [27].”
BackgroundLendon, C. L., Han, B. H., Salimi, K., Fagan, A. M., Behrens, M. I., Muller, M. C., & Holtzman, D. M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00113.x · Cited by 26 · cited 1×
“Some studies of transgenic mice that overexpress ApoE3 or ApoE4 suggested a protective role of ApoE3 against excitotoxicity compared to ApoE4 [55,56] whereas other studies revealed no differences [57,58].”
ResultMoore, C. L., Diehl, T. S., Selkoe, D. J., & Wolfe, M. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06922.x · Cited by 21 · cited 1×
“Such an Aβ rise at sub-threshold concentrations of γ-secretase inhibitors has been described in cell culture [47,48] and in vivo in human [49].”
BackgroundOverexpression of apolipoprotein E4 increases kainic-acid-induced hippocampal neurodegeneration
Zhang, X., Mao, X., Zhang, H., Zheng, X., Pham, T. M., Adem, A., Winblad, B. G., Mix, E., & Zhu, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.024 · Cited by 14
Cited by
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Mertens, J., Reid, D., Lau, S., Kim, Y., & Gage, F. H. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031534 · Cited by 255
Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death
Calvo-Rodriguez, M., & Bacskai, B. J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.004 · Cited by 254
Metadata
- Authors
- Duan, L., Bhattacharyya, B. J., Belmadani, A., Pan, L., Miller, R. J., & Kessler, J. A.
- Venue
- Molecular Neurodegeneration
- Published
- 2014
- Volume
- 9
- Issue
- 1
- Pages
- 3
- ISSN
- 1750-1326 (ISSN-L)
- OpenAlex
- W2138456699
- Cited by
- 159
- References
- 67
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.